Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALStandard

LIDOCAINE AND PRILOCAINE

LIDOCAINE; PRILOCAINE

Standard Dose
2.5%;2.5%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview LIDOCAINE AND PRILOCAINE is listed in Drugs@FDA under application 219120 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LIDOCAINE; PRILOCAINE Form and strength CREAM;TOPICAL - 2.5%;2.5% Sponsor ZYDUS LIFESCIENCES Submission history Latest submission status date: 2024-12-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview LIDOCAINE AND PRILOCAINE is listed in Drugs@FDA under application 219120 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LIDOCAINE; PRILOCAINE Form and strength CREAM;TOPICAL - 2.5%;2.5% Sponsor ZYDUS LIFESCIENCES Submission history Latest submission status date: 2024-12-17 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.